Hormone replacement therapy among postmenopausal women presenting with acute myocardial infarction

Insights from the GUSTO-III trial

Andrea H. Tackett, Alison L. Bailey, Joanne Micale Foody, Julie M Miller, Carolyn Apperson-Hansen, E. Magnus Ohman, Judith S. Hochman, Sharon L. Karnash, Robert M. Califf, Eric J. Topol, David J. Moliterno

Research output: Contribution to journalArticle

Abstract

Background: The role of hormone replacement therapy (HRT) in the prevention of cardiovascular disease has been controversial. In large observational studies, HRT appears to lower cardiovascular disease risk. However, prospective randomized trials do not substantiate this. Methods: We sought to characterize the use of HRT in women presenting with acute myocardial infarction and to investigate an association between HRT and inhospital or 30-day outcomes among women enrolled in the Global Use of Strategies to Open Occluded Coronary Arteries III (GUSTO-III) trial. Of the 15 059 patients in GUSTO-III, 4124 were women. Menopausal status, HRT use, and clinical outcomes data were prospectively collected. Results: Postmenopausal women taking HRT were significantly younger than those not taking HRT, and US women were more likely to be prescribed HRT than non-US women. While unadjusted 30-day mortality was substantially lower in HRT patients (6.1% vs 12.7%, P <.001), HRT use was not independently predictive of mortality after correcting for baseline differences (χ2 = 0.15, P = .70). Conclusion: Hormone replacement therapy appears to have no early mortality benefit in women sustaining acute myocardial infarction. These findings further challenge the role of HRT in cardiovascular medicine.

Original languageEnglish (US)
Pages (from-to)678-684
Number of pages7
JournalAmerican Heart Journal
Volume160
Issue number4
DOIs
StatePublished - 2010

Fingerprint

Estrogen Replacement Therapy
Hormone Replacement Therapy
Myocardial Infarction
Mortality
Cardiovascular Diseases
Observational Studies
Coronary Vessels
Medicine

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Medicine(all)

Cite this

Hormone replacement therapy among postmenopausal women presenting with acute myocardial infarction : Insights from the GUSTO-III trial. / Tackett, Andrea H.; Bailey, Alison L.; Foody, Joanne Micale; Miller, Julie M; Apperson-Hansen, Carolyn; Ohman, E. Magnus; Hochman, Judith S.; Karnash, Sharon L.; Califf, Robert M.; Topol, Eric J.; Moliterno, David J.

In: American Heart Journal, Vol. 160, No. 4, 2010, p. 678-684.

Research output: Contribution to journalArticle

Tackett, AH, Bailey, AL, Foody, JM, Miller, JM, Apperson-Hansen, C, Ohman, EM, Hochman, JS, Karnash, SL, Califf, RM, Topol, EJ & Moliterno, DJ 2010, 'Hormone replacement therapy among postmenopausal women presenting with acute myocardial infarction: Insights from the GUSTO-III trial', American Heart Journal, vol. 160, no. 4, pp. 678-684. https://doi.org/10.1016/j.ahj.2010.06.030
Tackett, Andrea H. ; Bailey, Alison L. ; Foody, Joanne Micale ; Miller, Julie M ; Apperson-Hansen, Carolyn ; Ohman, E. Magnus ; Hochman, Judith S. ; Karnash, Sharon L. ; Califf, Robert M. ; Topol, Eric J. ; Moliterno, David J. / Hormone replacement therapy among postmenopausal women presenting with acute myocardial infarction : Insights from the GUSTO-III trial. In: American Heart Journal. 2010 ; Vol. 160, No. 4. pp. 678-684.
@article{a4d6288495794e6aa25d4525e1f3707f,
title = "Hormone replacement therapy among postmenopausal women presenting with acute myocardial infarction: Insights from the GUSTO-III trial",
abstract = "Background: The role of hormone replacement therapy (HRT) in the prevention of cardiovascular disease has been controversial. In large observational studies, HRT appears to lower cardiovascular disease risk. However, prospective randomized trials do not substantiate this. Methods: We sought to characterize the use of HRT in women presenting with acute myocardial infarction and to investigate an association between HRT and inhospital or 30-day outcomes among women enrolled in the Global Use of Strategies to Open Occluded Coronary Arteries III (GUSTO-III) trial. Of the 15 059 patients in GUSTO-III, 4124 were women. Menopausal status, HRT use, and clinical outcomes data were prospectively collected. Results: Postmenopausal women taking HRT were significantly younger than those not taking HRT, and US women were more likely to be prescribed HRT than non-US women. While unadjusted 30-day mortality was substantially lower in HRT patients (6.1{\%} vs 12.7{\%}, P <.001), HRT use was not independently predictive of mortality after correcting for baseline differences (χ2 = 0.15, P = .70). Conclusion: Hormone replacement therapy appears to have no early mortality benefit in women sustaining acute myocardial infarction. These findings further challenge the role of HRT in cardiovascular medicine.",
author = "Tackett, {Andrea H.} and Bailey, {Alison L.} and Foody, {Joanne Micale} and Miller, {Julie M} and Carolyn Apperson-Hansen and Ohman, {E. Magnus} and Hochman, {Judith S.} and Karnash, {Sharon L.} and Califf, {Robert M.} and Topol, {Eric J.} and Moliterno, {David J.}",
year = "2010",
doi = "10.1016/j.ahj.2010.06.030",
language = "English (US)",
volume = "160",
pages = "678--684",
journal = "American Heart Journal",
issn = "0002-8703",
publisher = "Mosby Inc.",
number = "4",

}

TY - JOUR

T1 - Hormone replacement therapy among postmenopausal women presenting with acute myocardial infarction

T2 - Insights from the GUSTO-III trial

AU - Tackett, Andrea H.

AU - Bailey, Alison L.

AU - Foody, Joanne Micale

AU - Miller, Julie M

AU - Apperson-Hansen, Carolyn

AU - Ohman, E. Magnus

AU - Hochman, Judith S.

AU - Karnash, Sharon L.

AU - Califf, Robert M.

AU - Topol, Eric J.

AU - Moliterno, David J.

PY - 2010

Y1 - 2010

N2 - Background: The role of hormone replacement therapy (HRT) in the prevention of cardiovascular disease has been controversial. In large observational studies, HRT appears to lower cardiovascular disease risk. However, prospective randomized trials do not substantiate this. Methods: We sought to characterize the use of HRT in women presenting with acute myocardial infarction and to investigate an association between HRT and inhospital or 30-day outcomes among women enrolled in the Global Use of Strategies to Open Occluded Coronary Arteries III (GUSTO-III) trial. Of the 15 059 patients in GUSTO-III, 4124 were women. Menopausal status, HRT use, and clinical outcomes data were prospectively collected. Results: Postmenopausal women taking HRT were significantly younger than those not taking HRT, and US women were more likely to be prescribed HRT than non-US women. While unadjusted 30-day mortality was substantially lower in HRT patients (6.1% vs 12.7%, P <.001), HRT use was not independently predictive of mortality after correcting for baseline differences (χ2 = 0.15, P = .70). Conclusion: Hormone replacement therapy appears to have no early mortality benefit in women sustaining acute myocardial infarction. These findings further challenge the role of HRT in cardiovascular medicine.

AB - Background: The role of hormone replacement therapy (HRT) in the prevention of cardiovascular disease has been controversial. In large observational studies, HRT appears to lower cardiovascular disease risk. However, prospective randomized trials do not substantiate this. Methods: We sought to characterize the use of HRT in women presenting with acute myocardial infarction and to investigate an association between HRT and inhospital or 30-day outcomes among women enrolled in the Global Use of Strategies to Open Occluded Coronary Arteries III (GUSTO-III) trial. Of the 15 059 patients in GUSTO-III, 4124 were women. Menopausal status, HRT use, and clinical outcomes data were prospectively collected. Results: Postmenopausal women taking HRT were significantly younger than those not taking HRT, and US women were more likely to be prescribed HRT than non-US women. While unadjusted 30-day mortality was substantially lower in HRT patients (6.1% vs 12.7%, P <.001), HRT use was not independently predictive of mortality after correcting for baseline differences (χ2 = 0.15, P = .70). Conclusion: Hormone replacement therapy appears to have no early mortality benefit in women sustaining acute myocardial infarction. These findings further challenge the role of HRT in cardiovascular medicine.

UR - http://www.scopus.com/inward/record.url?scp=77957854061&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957854061&partnerID=8YFLogxK

U2 - 10.1016/j.ahj.2010.06.030

DO - 10.1016/j.ahj.2010.06.030

M3 - Article

VL - 160

SP - 678

EP - 684

JO - American Heart Journal

JF - American Heart Journal

SN - 0002-8703

IS - 4

ER -